In vitro motility studies of HCM and DCM mutations in cardiac muscle actin

In vitro motility studies of HCM and DCM mutations in cardiac muscle actin

Bibliographic Details
Main Authors:	Dyer, E, Wells, D, Redwood, C, Marston, S
Format:	Conference item
Published:	2007

Similar Items

HCM and DCM mutations in thin filament proteins have opposite effects on in vitro motility
by: Marston, S, et al.
Published: (2002)

HCM and DCM mutations in cardiac thin filament proteins have opposite effects on the regulation of contractility in vitro
by: Redwood, C, et al.
Published: (2003)

HCM and DCM mutations in thin filament proteins have opposite effects on regulation of contractility in vitro
by: Redwood, C, et al.
Published: (2003)

Mutations in tropomyosin that cause DCM, affect cooperativity of cardiac muscle thin filaments
by: Marston, S, et al.
Published: (2007)

Functional investigation of a transgenic mouse model of dilated cardiomyopathy with the Glu361Gly mutation in cardiac actin
by: Dyer, E, et al.
Published: (2006)

Mouse HCM Model Expression E99K ACTC Mutation Reproduces the Clinical HCM Phenotype
by: Song, W, et al.
Published: (2009)

Autosomal dominant HCM and DCM phenotype caused by a novel mutation in phospholamban
by: Carballo, S, et al.
Published: (2004)

Two DCM mutations in cardiac tropomyosin alter thin filament function by different mechanisms
by: Marston, S, et al.
Published: (2007)

Investigation of a mouse model of familial DCM with ACTC E361G mutation
by: Song, W, et al.
Published: (2008)

Evidence for haploinsufficiency as the mechanism of action of MyBP-C mutations that cause HCM
by: Carballo, S, et al.
Published: (2008)

The effect of HCM mutations in troponin T and troponin I on the calcium binding of human cardiac troponin
by: Redwood, C, et al.
Published: (2001)

The HCM-associated cardiac Troponin T mutation K280N causes reduced responsiveness to protein kinase A
by: Van Der Velden, J, et al.
Published: (2012)

Effects of DCM mutations in thin filament regulatory proteins on contractile function
by: Robinson, P, et al.
Published: (2005)

The HCM-Associated Cardiac Troponin T Mutation K280N Increases the Energetic Cost of Tension Generation in Human Cardiac Myofibrils
by: Ferrara, C, et al.
Published: (2013)

MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM
by: Mengmeng Li, et al.
Published: (2018-06-01)

Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay.
by: Bing, W, et al.
Published: (2000)

Interaction analyses elucidate the pathophysiology of HCM-causing missense mutations in cardiac myosin binding protein-C.
by: Moolman-Smook, J, et al.
Published: (2001)

Functional investigation of troponin with the homozygous HCM mutation, TNNT2 K280N, obtained from an explanted heart
by: Bayliss, C, et al.
Published: (2012)

A revised method of troponin exchange in permeabilised cardiac trabeculae using vanadate: functional consequences of a HCM-causing mutation in troponin I.
by: Preston, L, et al.
Published: (2006)

Molecular mechanism of the E99K mutation in cardiac actin (ACTC Gene) that causes apical hypertrophy in man and mouse.
by: Song, W, et al.
Published: (2011)

Functional significance of HCM mutants of tropomyosin, V95A and D175N, studied with in vitro motility assays
by: Shuya Ishii, et al.
Published: (2019-02-01)

Functional effects of the DCM mutant Gly159Asp troponin C in skinned muscle fibres.
by: Preston, L, et al.
Published: (2007)

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
by: Carballo, S, et al.
Published: (2005)

Familial Dilated Cardiomyopathy Caused by an Alpha-Tropomyosin Mutation: The Distinctive Natural History of Sarcomeric DCM
by: Lakdawala, N, et al.
Published: (2009)

DCM troponin C mutant Gly159Asp blunts the response to troponin phosphorylation.
by: Preston, L, et al.
Published: (2007)

Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility.
by: Burton, D, et al.
Published: (2002)

A novel interaction between the C5 and C8 domains of myosin binding protein-C and its modulation by HCM mutations
by: Flashman, E, et al.
Published: (2002)

Actin remodeling in motile cells
by: Osborn, Eric A. (Eric Alan), 1975-
Published: (2005)

Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
by: Marilena Melas, et al.
Published: (2022-12-01)

Acceleration of the sliding movement of actin filaments with the use of a non-motile mutant myosin in in vitro motility assays driven by skeletal muscle heavy meromyosin.
by: Kohei Iwase, et al.
Published: (2017-01-01)

Actin filament attachments for sustained motility in vitro are maintained by filament bundling.
by: Xiaohua Hu, et al.
Published: (2012-01-01)

The DCM Project Portal: A direct-to-participant platform of The DCM Research Project
by: Elizabeth S. Jordan, et al.
Published: (2024-02-01)

Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death.
by: Dass, S, et al.
Published: (2012)

Effects of hypertrophic cardiomyopathy mutations in troponin I on contractility of skinned cardiac muscle fibres
by: Burton, D, et al.
Published: (2002)

P123The rescue of Ca2+ cycling abnormalities conferred by HCM-causing mutations with analogues of the green tea polyphenol epigallocatechin-3-gallate.
by: Robinson, P, et al.
Published: (2014)

Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin.
by: Nowak, K, et al.
Published: (2009)

Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability
by: Cai Shaoxi, et al.
Published: (2010-02-01)

ATTR Gene Variants in HCM
by: Anthony J. Kanelidis, MD, et al.
Published: (2024-03-01)

ECG changes and their prognostic value for the development of sudden cardiac death in HCM patients
by: V.Y. Tseluyko, et al.
Published: (2023-12-01)

Two mutations in human cardiac troponin I known to cause hypertrophic cardiomyopathy have different effects on cardiac muscle contraction
by: Burton, D, et al.
Published: (2000)